Copy Link Print Information

Sacituzumab govitecan

(Synonyms: IMMU-132)
11 Cited Publications
Customer Review

Based on 11 publication(s) in Google Scholar

Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity.

For research use only. We do not sell to patients.

  • Purity: 98.02%
  • CAS No.: 1491917-83-9
  • Molecular Weight:157364 (average)
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Sacituzumab govitecan Chemical Structure
    Sacituzumab govitecan Chemical Structure
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
  • Experimental Validation Results for Sacituzumab govitecan
CAS No.: 1491917-83-9
Size
Price
Stock
Quantity
Amount: USD 0.00
Please select quantity
or
or

* Please select Quantity before adding items.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Sacituzumab govitecan:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Find Your Local Distributor Your local distributor: Hycultec GmbHHycultec
  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Sacituzumab govitecan

More
Customer Validation & Images
Cell Imaging/StainingCell Proliferation/Viability AssayIn Vivo Efficacy StudyBio/Physico-chemical AssayIn Vivo Imaging
  • Cell Imaging/Staining
  • Cell Proliferation/Viability Assay
  • Cell Imaging/Staining
  • Bio/Physico-chemical Assay
  • Cell Proliferation/Viability Assay
  • In Vivo Efficacy Study
  • In Vivo Imaging
Keywords
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Register
Sign in to MedChemExpress
Register New Account

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Sacituzumab govitecan Chemical Structure
    Sacituzumab govitecan Chemical Structure
    1/16
  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]

    Customer Validation
     Cell morphology was observed under a microscope (SG, 10 nM, 24 h) (Scale bar: 100 µm).

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]

    Customer Validation
     Cell viability was assessed after 24 h of treatment with 10 nM SG at various concentrations using the CCK-8 assay.

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]

    Customer Validation
     Representative fluorescence images and quantification of tail moment in parental and resistant cells (SG, 10 nM, 24 h).

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]

    Customer Validation
     The heatmap displays gene expression in the resistant group compared to the parental group in MCF-7 cells (SG, 10 nM, 24 h). The colors of the heatmap reflect log2 expression levels of genes.

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2025 Apr 26;16(1):346. [Abstract]

    Customer Validation
     After knockdown of BCL2A1, WFDC3, PI3, CLDN5, and MMP1 separately, the viability of MCF-7-Pa and T47D-Pa was tested at different concentrations of SG (0-200 nM) using CCK-8 assays.

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Anal Chem. 2025 Oct 28;97(42):23598-23608. [Abstract]

    Customer Validation
     Time course of tumor volume of MDA-MB-468 tumor-bearing mice treated with PBS, SG (10 mg/kg, tail vein injection), and Dato-DXd (10 mg/kg, tail vein injection).

  • 1/16

    Sacituzumab govitecan purchased from MedChemExpress. Usage Cited in: Anal Chem. 2025 Oct 28;97(42):23598-23608. [Abstract]

    Customer Validation
     MicroPET imaging of MDA-MB-468 tumor-bearing mice at different time postinjection of [68Ga]Ga-NOTA-PEG2-WP8 during PBS, SG (10 mg/kg, tail vein injection) and Dato-DXd (10 mg/kg, tail vein injection) treatment for 0, 9, and 18 days, respectively. White dotted line circles indicate the tumor locations.

  • Sacituzumab govitecan